MedCap AB (publ) OMXSTO:MCAP:
COMPLETES BUYBACK PROGRAM WITH 46,658 SHARES REPURCHASED FOR SEK 24,996,622
MedCap Completes Buyback Program
Earlier from MedCap
- MCAP: Q1 2026 delivered double-digit revenue and profit growth, driven by strong segment performance
- MedCap (Q4 review): Beat on Solid Organic Growth
- MCAP: Record sales and EBITA growth in 2025, supported by strong operations and acquisitions
- MCAP: Life science group achieves robust growth via acquisitions and innovation in core business areas
- MCAP: Q3 2025 delivered 21% sales growth, 32% EBITA growth, and strong segment performance
Later from MedCap
All MedCap news releasesFollow MedCap into a list and get an email when it puts out news.
Follow MedCap